Stem Cells and Development
ISSN 1547-3287 · Mary Ann Liebert, Inc. · United States · active 1957–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Is this the right journal for your paper?
The AI Journal Finder ranks the best-matched journals for your paper’s topic — with tier, open access, citation rate and predatory flags. Free to start.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Stem Cells and Development a predatory journal?
Our screening does not flag Stem Cells and Development. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Stem Cells and Development indexed in Scopus or Web of Science?
Per our venue index, Stem Cells and Development appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is the impact factor of Stem Cells and Development?
Papers in Stem Cells and Development are cited about 2.3 times each within two years of publication, and Scimago places it in Q3, with an h-index of 151. Those are the open equivalents: the Clarivate Journal Impact Factor is a proprietary metric we neither compute nor license, so we show the two-year citation rate and Scimago quartile instead — they answer the same question of how heavily the journal is cited. A citation rate is a property of a field as much as of a journal.
What Scimago quartile is Stem Cells and Development (Q1, Q2, Q3, or Q4)?
Scimago places Stem Cells and Development in Q3 for its subject category. Quartiles split the journals in a field into four equal groups by SJR, so Q1 is the most-cited quarter and Q4 the least; Stem Cells and Development is cited about 2.3 times per paper over two years, with an h-index of 151. A journal is ranked per subject category, so one spanning several fields can sit in different quartiles depending on the category.
What is the Web of Science (JCR) quartile of Stem Cells and Development?
The Web of Science quartile comes from Clarivate's Journal Citation Reports (JCR), a proprietary product we neither license nor compute — so we cannot state a JCR quartile for Stem Cells and Development. The open equivalent is its Scimago quartile, Q3, derived from Scopus citation data. Because JCR ranks against Web of Science and Scimago against Scopus, the two can differ, so check Clarivate's site directly if you need the JCR quartile specifically.
Is Stem Cells and Development open access?
We hold no reliable open-access classification for Stem Cells and Development. Check the journal's own site for its access model and any article processing charge.